Labs / ADME, DMPK & toxicology
Grove Biopharma
Chicago, IL, United States · grovebiopharma.com
Grove Biopharma develops Bionic Biologics™, a synthetic biologics platform for targeting intracellular protein-protein interactions. It is based in Chicago, with compute infrastructure in Toronto, and works on therapeutics for cancer, neurodegenerative diseases, rare disorders, and myocardial infarction.
They take quote requests by email.
What they offer
AI-enabled molecular design
Uses AI/ML and physics-based computational design to identify target-binding peptides and design molecules against challenging targets.
Precision polymer chemistry
Assembles peptide inputs into protein-scale molecules through a novel precision polymerization process.
Experimental biology
Combines experimental biology with the platform to create proprietary Bionic Biologics against intracellular protein-protein interaction targets.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Peptide
- Species and models
- animal models, rodent
- Assays and studies
- structural biology, phage display, small-angle X-ray scattering (SAXS)
- Therapeutic areas
- cancer, neurodegenerative diseases, rare disorders, myocardial infarction
- Sites
- Chicago, USA · Toronto, Canada
- Founded
- 2025
Similar labs. Sparx BIO, AbTherx, Aurigene Pharmaceutical Services, Bioneeds
Found in a contract services directory. Listing built from grovebiopharma.com. Work here? Claim this listing.